VECT(Delisted)
VectivBio HoldingยทNASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About VECT
Vectivbio Holding Ag
A Switzerland-based clinical-stage biopharma that develops treatments for rare gastrointestinal and metabolic disorders
Aeschenvorstadt 36, 4051 Basel, Switzerland
--
VectivBio Holding AG was founded in Switzerland on May 22, 2019. They are a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing innovative treatments for serious rare diseases. Their goal is to become a leading, patient-centric, fully integrated global rare disease company. Their current product line focuses on rare gastrointestinal diseases or gastrointestinal diseases.
Company Financials
EPS
VECT has released its 2021 Q3 earnings. EPS was reported at -2.08, versus the expected 0, missing expectations. The chart below visualizes how VECT has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
